Buscar resultados de ensayos clínicos
Nasopharyngeal Carcinoma - 33 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: Camrelizumab After Completion of Radiotherapy for Oligometastatic Nasopharyngeal Carcinoma Condición: Nasopharyngeal Carcinoma Fecha: 2025-09-05 Intervenciones: Camrelizumab 200mg every 21 days (3 weeks) for up to 18 cycles, from 4 to 12 weeks after the completion of radiotherapy. |
| COMPLETED |
Nombre del estudio: Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma Condición: Nasopharyngeal Carcinoma Fecha: 2025-09-05 Intervenciones: On the first and second days of induction chemotherapy, lymph nodes were irradiated with 0.5Gy bid for 4 times. |
| COMPLETED |
Nombre del estudio: Toripalimab and Anlotinib Combination Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma After Failure of at Least One Line of Platinum-Based Chemotherapy (TORAL) Condición: Nasopharyngeal Carcinoma Fecha: 2025-09-05 Intervenciones: Toripalimab 240 mg iv.drip d1; Anlotinib 12mg po qd d1-14. |